Breier G. .2000 .21 Suppl A:S11-5.. Placenta, : .
Coppola R,Santo B,Ramella S,Panasiti V .2021 .Novel skin toxicity of epidermal growth factor receptor inhibitors: A case of intertrigo-like eruption in a patient with metastatic colorectal cancer treated with cetuximab. Clin Cancer Investig J, 10(2) : 91-2.
Mahmood H,Shahid AM,Usama M,Nadeem E,Zafar N,Bashir R .2022 .Relation between periodontitis and systemic health among young dental practitioners in twin cities of Pakistan. , 10(3) : 7-11.
Turkistani S,Alotaibi N,Alanazi MM,Alsanie SA,Hussain BS,Hasan S. .2022 .Efficacy of glass fiber composite restoration: A systematic review. Arch Pharm Pract, 13(3) : 123.
Mostafaei A,Mohammadi Motlagh HR,Mansouri K. .2010 .Angiogenesis and the models to study Angiogenesis. Cell J, 11(4) : 374-81.
Fox SB,Gasparini G,Harris AL .2001 .Angiogenesis: Pathological, prognostic, and growth-factor pathways and their link to trial design and anticancer drugs. Lancet Oncol, 2(5) : 278-89.
Nebotova LV,Gasanov EA,Makhsubova SH,Abdullayeva ZA,Shabaev SM,Kadiev IA .2023 .Methods of treatment of hemangiomas. Clin Cancer Investig J, 12(2) : 33-8.
Özatik Ş,Saygılı S,Sülün T,Alan CB .2022 .Semi-digital workflow of removable partial denture fabrication for scleroderma-induced microstomia patients: Two clinical reports. Ann Dent Spec, 10(3) : 1-6.
Bielenberg DR,D'Amore PA. Judah DR .2008 .Folkman's contribution to the inhibition of angiogenesis. Lymphat Res Biol, 6(3) : 203-7.
Brem H,Folkman J .1975 .Inhibition of tumor angiogenesis mediated by cartilage. J Exp Med, 141(2) : 427-39.
Bakhuraysah MM .2022 .Immunity and therapeutic approaches against coronavirus disease 2019. Arch Pharm Pract, 13(3) : 105-11.
Dogan I,Khanmammadov N,Ahmed MA,Yıldız A,Saip P,Aydiner A .2022 .Outcomes and prognostic factors in patients with EGFR mutant metastatic non-small cell lung cancer who treated with Erlotinib. Clin Cancer Investig J, 11(4) : 5-9.
Folkman J.,Angiogenesis J. .2006 .. Annu Rev Med, 57 : 1-8.
Weidner N,Folkman J,Pozza F,Bevilacqua P,Allred EN,Moore DH .1992 .Tumor angiogenesis: A new significant and independent prognostic indicator in early-stage breast carcinoma. J Natl Cancer Inst, 84(24) : 1875-87.
Poornachitra P,Maheswari U .2022 .Prevalence of non-specific chief complaints in patients with oral submucous fibrosis. Ann Dent Spec, 10(3) : 59-63.
Elsawy A,Alkhalaf R,Binnjefan S,Alkhalaf K,Alhumaidan S,Haridy R .2022 .Temporomandibular disorders: A cross sectional study into the knowledge and awareness among Saudi Arabian population. Arch Pharm Pract, 13(3) : 116-21.
'Reilly O,Boehm MS,Shing T,Fukai Y,Vasios N,Lane G,WS G .1997 .Endostatin: An endogenous inhibitor of angiogenesis and tumor growth. Cell, 88(2) : 277-85.
Talu H,Taşindi E,Ciftci F,Yildiz TF .1998 .Excimer laser phototherapeutic keratectomy for recurrent pterygium. J Cataract Refract Surg, 24(10) : 1326-32.
Singh G,Goel N,Singh A,Gera R .2022 .Study of factors affecting the time to diagnosis and treatment in pediatric acute leukemia patients- a study from India. Clin Cancer Investig J, 11(3) : 35-40.
Robson MC,Payne WG,Garner WL,Biundo J,Giacalone VF,Cooper DM .2005 .Integrating the results of phase IV (postmarketing) clinical trial with four previous trials reinforces the position that Regranex (Becaplermin) Gel 0.01% is an effective adjunct to the treatment of diabetic foot ulcers. J Appl Res, 5 : 35-45.
Shimizu K,Oku N. .2004 .Cancer anti-angiogenic therapy. Biol Pharm Bull, 27(5) : 599-605.
Kerbel RS,Kamen BA .2004 .The anti-angiogenic basis of metronomic chemotherapy. Nat Rev Cancer, 4(6) : 423-36.
Gupta K,Zhang J,Angiogenesis J .2005 .A curse or cure? Postgrad Med. , 81(954) : 236-42.
Cines DB,Pollak ES,Buck CA,Loscalzo J,Zimmerman GA,McEver RP .1998 .Endothelial cells in physiology and in the pathophysiology of vascular disorders. Blood, 91(10) : 3527-61.
Verstraete M.,Vane JR,Born GVR,Welzel D .1995 .Endothelial cell-mediated coagulation, anticoagulation and fibrinolysis. In: The Endothelial Cell in Health and Disease, : 147-64.
Kusaka M,Sudo K,Fujita T,Marui S,Itoh F,Ingber D .1991 .Potent anti-angiogenic action of AGM-1470: Comparison to the fumagillin parent. Biochem Biophys Res Commun, 174(3) : 1070-6.
Gupta SK,Hassel T,Singh JP,Natl Acad Sci U S A Proc .1995 .A potent inhibitor of endothelial cell proliferation is generated by proteolytic cleavage of the chemokine platelet factor 4. , 92(17) : 7799-803.
Lee JH,Chun T,Park SY,Rho SB .2008 .Interferon regulatory factor-1 (IRF1) regulates VEGF-induced angiogenesis in HUVECs. Biochim Biophys Acta, 1783(9) : 1654-62.
'Reilly O,Holmgren MS,Shing L,Chen Y,Rosenthal C,Moses RA,M RA .1994 .Angiostatin: A novel angiogenesis inhibitor that mediates the suppression of metastases by a Lewis lung carcinoma. Cell, 79(2) : 315-28.
Streck CJ,Ng CY,Zhang Y,Zhou J,Nathwani AC,Davidoff AM .2005 .Interferon-mediated anti-angiogenic therapy for neuroblastoma. Cancer Lett, 228(1-2) : 163-70.
Gruner S,Liebenthal C,Heusser C,Brinkmann V,Zwirner A,Reinicke C .1991 .The influence of interferon-gamma and interleukin-4 on IgE production in B lymphocytes of patients with atopic dermatitis. A possible criterion for selection of patients for interferon therapy. Acta Derm Venereol, 71(6) : 484-7.
Kim KJ,Li B,Winer J,Armanini M,Gillett N,Phillips HS .1993 .Inhibition of vascular endothelial growth factor-induced angiogenesis suppresses tumour growth in vivo. Nature, 362(6423) : 841-4.
Goto F,Goto K,Weindel K,Folkman J .1993 .Synergistic effects of vascular endothelial growth factor and basic fibroblast growth factor on the proliferation and cord formation of bovine capillary endothelial cells within collagen gels. Lab Invest, 69(5) : 508-17.
Hanahan D,Folkman J .1996 .Patterns and emerging mechanisms of the angiogenic switch during tumorigenesis. Cell, 86(3) : 353-64.
Shakiba Y,Mansouri K,Arshadi D,Rezaei N. .2009 .Corneal neovascularization: Molecular events and therapeutic options. Recent Pat Inflamm Allergy Drug Discov, 3(3) : 221-31.
Shweiki D,Itin A,Soffer D,Keshet E .1992 .Vascular endothelial growth factor induced by hypoxia may mediate hypoxia-initiated angiogenesis. Nature, 359(6398) : 843-5.
Davis S,Aldrich TH,Jones PF,Acheson A,Compton DL,Jain V .1996 .Isolation of angiopoietin-1, a ligand for the TIE2 receptor, by secretion-trap expression cloning. Cell, 87(7) : 1161-9.
Kohn S,Nagy JA,Dvorak HF,Dvorak AM .1992 .Pathways of macromolecular tracer transport across venules and small veins. Structural basis for the hyperpermeability of tumor blood vessels. Lab Invest, 67(5) : 596-607.
Kevil CG,Payne DK,Mire E,Alexander JS .1998 .Vascular permeability factor/vascular endothelial cell growth factor-mediated permeability occurs through disorganization of endothelial junctional proteins. J Biol Chem, 273(24) : 15099-103.
Vila V,Martínez-Sales V,Almenar L,Lázaro IS,Villa P,Reganon E .2008 .endothelial dysfunction and angiogenesis markers in chronic heart failure patients. Int J Cardiol, 130(2) : 276-7.
Kiefer FN,Munk VC,Humar R,Dieterle T,Landmann L,Battegay EJ .2004 .A versatile in vitro assay for investigating angiogenesis of the heart. Exp Cell Res, 300(2) : 272-82.
Grass TM,Lurie DI,Coffin JD .2006 .Transitional angiogenesis and vascular remodeling during coronary angiogenesis in response to myocardial infarction. Acta Histochem, 108(4) : 293-302.
Renault MA,Losordo DW .2007 .Therapeutic myocardial angiogenesis. Microvasc Res, 74(2-3) : 159-71.
Hilfiker-Kleiner D,Landmesser U,Drexler H U .2006 .Molecular mechanisms in heart failure: Focus on cardiac hypertrophy, inflammation, angiogenesis, and apoptosis. J Am Coll Cardiol, 48(9) : 56-66.
Epstein SE,Stabile E,Kinnaird T,Lee CW,Clavijo L,Burnett MS .2004 .Janus phenomenon: The interrelated tradeoffs inherent in therapies designed to enhance collateral formation and those designed to inhibit atherogenesis. Circulation, 109(23) : 2826-31.
Margolin K,Gordon MS,Holmgren E,Gaudreault J,Novotny W,Fyfe G .2001 .Phase Ib trial of intravenous recombinant humanized monoclonal antibody to vascular endothelial growth factor in combination with chemotherapy in patients with advanced cancer: Pharmacologic and long-term safety data. J Clin Oncol, 19(3) : 851-6.
Stamenkovic I. .2000 .Matrix metalloproteinases in tumor invasion and metastasis. Semin Cancer Biol, 10(6) : 415-33.
Kleiner DE,Stetler-Stevenson WG .1999 .Matrix metalloproteinases and metastasis. Cancer Chemother Pharmacol, 43 : S42-51.
Zucker S,Cao J,Chen WT .2000 .Critical appraisal of the use of matrix metalloproteinase inhibitors in cancer treatment. Oncogene, 19(56) : 6642-50.
Hua J,Muschel RJ .1996 .Inhibition of matrix metalloproteinase 9 expression by a ribozyme blocks metastasis in a rat sarcoma model system. Cancer Res, 56(22) : 5279-84.